YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05913804 · RECRUITING
Trial details
- NCT number
- NCT05913804
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2025-12-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.